COSCIENS Biopharma Inc.

CSCI · NASDAQ

$2.72 -4.56% (-$0.13)

Analiza

AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.

Piotroski F-Score Weak

3/9

Valuation

N/A

PEG N/A

P/E N/A

P/FFO N/A

Growth

N/A

FCF growth N/A

EPS growth N/A

Book val. growth N/A

Profitability

N/A

Op. margin N/A

Gross margin N/A

FCF margin N/A

Quality

N/A

ROA N/A

ROIC N/A

Asset turnover N/A

Debt

N/A

Int. coverage N/A

Debt/Equity N/A

Net debt/EBITDA N/A

Stability

4 /100

Unstable

Beta 1.85x

Profitable years N/A

Rev. volatility N/A

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o CSCI

Online

Sector

Healthcare

Industry

Biotechnology

CEO

Anna Elizabeth Biehn

Employees

Headquarters

Toronto

⌘ K

StockBot Live

Tržne razmere Wall Street

Cenejša nafta in tehnološke delnice krepita Wall Street

S&P 500 +0.40% in Dow +0.90% rasteta ob cenejši nafti. Microsoft +3.30% je poskočil zaradi novih orodij AI.

Vprašajte o tem

StockBot pozna 80,000+ delnic po vsem svetu